Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy

被引:31
作者
Duijm, Marloes [1 ]
Schillemans, W. [1 ]
Aerts, Joachim G. [2 ]
Heijmen, B. [1 ]
Nuyttens, Joost J. [1 ]
机构
[1] Erasmus MC Canc Inst, Dept Radiat Oncol, Postbus 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC Canc Inst, Dept Pulmonol, Rotterdam, Netherlands
关键词
BODY RADIATION-THERAPY; PHASE-II; CANCER; TOXICITY; BRACHYTHERAPY; CYBERKNIFE; STENOSIS; RISK;
D O I
10.1016/j.semradonc.2015.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High radiation dose to the main bronchi can result in stenosis, occlusion or fistula formation, and death. Only 8 articles have reported side effects to the main bronchi from stereotactic body radiation therapy (SBRD, mostly with only one symptomatic complication per article. Therefore, we calculated the dose to the bronchial structures, such as trachea; mainstem bronchi; intermediate bronchus; upper-, middle-, and lower-lobe bronchus; and the segmental bronchi in 134 patients with central tumors and calculated the normal tissue complication probability (NTCP) for each of these structures, with toxicity determination based upon computed tomography imaging. No side effects were found in the trachea, and only stenosis occurred in the main bronchus and bronchus intermedius. Higher grades of side effects, such as occlusion and atelectasis, were only seen in the upper-, middle-, and lower bronchi and the segmental bronchi. When 0.5 cc of a segmental bronchi was irradiated to 50 Gy in 5 fractions, it was about 50% likely to be occluded radiographically. For grade 1 radiographically evident side effects, the 50% risk level for a 5-fraction D-max was 55 Gy for mid-bronchi and 65 Gy for mainstem bronchi. To assure the relationship between clinical toxicity and side effects to the bronchi, further investigation is needed. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 20 条
  • [1] Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
    Baumann, Pia
    Nyman, Jan
    Lax, Ingmar
    Friesland, Signe
    Hoyer, Morten
    Ericsson, Suzanne Rehn
    Johansson, Karl-Axel
    Ekberg, Lars
    Morhed, Elisabeth
    Paludan, Merete
    Wittgren, Lena
    Blomgren, Henrik
    Lewensohn, Rolf
    [J]. ACTA ONCOLOGICA, 2006, 45 (07) : 787 - 795
  • [2] PROSPECTIVE, RISK-ADAPTED STRATEGY OF STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: RESULTS OF A PHASE II TRIAL
    Bral, Samuel
    Gevaert, Thierry
    Linthout, Nadine
    Versmessen, Harijati
    Collen, Christine
    Engels, Benedikt
    Verdries, Douwe
    Everaert, Hendrik
    Christian, Nicolas
    De Ridder, Mark
    Storme, Guy
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1343 - 1349
  • [3] Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus
    Gollins, SW
    Ryder, WDJ
    Burt, PA
    Barber, PV
    Stout, R
    [J]. RADIOTHERAPY AND ONCOLOGY, 1996, 39 (02) : 105 - 116
  • [4] Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer
    Haasbeek, Cornelis J. A.
    Lagerwaard, Frank J.
    Slotman, Ben J.
    Senan, Suresh
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) : 2036 - 2043
  • [5] Stereotactic body radiation therapy for centrally located lung lesions
    Joyner, Melissa
    Salter, Bill J.
    Papanikolaou, Niko
    Fuss, Martin
    [J]. ACTA ONCOLOGICA, 2006, 45 (07) : 802 - 807
  • [6] Radiation-induced narrowing of the tracheobronchial tree: An in-depth analysis
    Kelsey, CR
    Kahn, D
    Hollis, DR
    Miller, KL
    Zhou, SM
    Clough, RW
    Marks, LB
    [J]. LUNG CANCER, 2006, 52 (01) : 111 - 116
  • [7] Long-term clinical experience of high-dose ablative lung radiotherapy: High pre-treatment [18F]Fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome
    Lee, Dong Soo
    Kim, Yeon Sil
    Yoo, Ie Ryung
    Kang, Young Nam
    Kim, Seoung Jun
    Oh, Jin Kyung
    Kim, Young Kyoon
    Wang, Young Pil
    Park, Jae Gil
    Kang, Jin-Hyoung
    Han, Dae Hee
    Ahn, Myung Im
    Lee, Kyo Young
    [J]. LUNG CANCER, 2013, 80 (02) : 172 - 178
  • [8] Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer?
    Miller, KL
    Shafman, TD
    Anscher, MS
    Zhou, SM
    Clough, RW
    Garst, JL
    Crawford, J
    Rosenman, J
    Socinski, MA
    Blackstock, W
    Sibley, GS
    Marks, LB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (01): : 64 - 69
  • [9] Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors
    Nuyttens, Joost J.
    van Zyp, Noelle C. van der Voort
    Praag, John
    Aluwini, Shafak
    van Klaveren, Rob J.
    Verhoef, Cornelis
    Pattynama, Peter M.
    Hoogeman, Mischa S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 102 (03) : 383 - 387
  • [10] Nuyttens JJ, 2012, EXPERT REV MED DEVIC, V9, P465, DOI [10.1586/erd.12.35, 10.1586/ERD.12.35]